Online citations, reference lists, and bibliographies.

Management Of Patients With Atrial Fibrillation.

Andrew D. Beaser, Adam S. Cifu
Published 2019 · Medicine
Cite This
Download PDF
Analyze on Scholarcy
This paper references
Rivaroxaban versus warfarin in nonvalvular atrial fibrillation.
Manesh R Patel (2011)
2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the Heart Rhythm Society.
Craig T. January (2019)
Apixaban versus warfarin in patients with atrial fibrillation.
Christopher B. Granger (2011)
Left Atrial Appendage Closure as an Alternative to Warfarin for Stroke Prevention in Atrial Fibrillation: A Patient-Level Meta-Analysis.
David R. Holmes (2015)
Rivaroxaban vs. vitamin K antagonists for cardioversion in atrial fibrillation.
Riccardo Cappato (2014)
Apixaban compared to heparin/vitamin K antagonist in patients with atrial fibrillation scheduled for cardioversion: the EMANATE trial
Michael D. Ezekowitz (2018)
Edoxaban versus warfarin in patients with atrial fibrillation.
Robert P Giugliano (2013)
Edoxaban versus enoxaparin–warfarin in patients undergoing cardioversion of atrial fibrillation (ENSURE-AF): a randomised, open-label, phase 3b trial
Andreas Goette (2016)
Catheter Ablation for Atrial Fibrillation with Heart Failure
Nassir F. Marrouche (2018)
Dabigatran versus warfarin in patients with atrial fibrillation.
Stuart J. Connolly (2009)

This paper is referenced by
Semantic Scholar Logo Some data provided by SemanticScholar